Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.
The Wall Street Journal on MSN15d
Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Aren’t Happy.Today was supposed to mark the beginning of the end for cheaper, knockoff versions of hot weight-loss drugs. The Food and ...
The pharmaceutical industry isn’t happy about President Donald Trump’s trade war and is reportedly lobbying the President to slow down drug ...
Pharma brands rely heavily on reassuring imagery, such as that cheerful couple strolling on a white-sand beach, but our audience isn’t buying it. One in two SiriusXM Media listeners say happy, ...
The drug industry won a reprieve from sweeping tariffs announced by President Donald Trump on Wednesday, though it could be ...
The happy answer to the above question is that ... It’s called repurposing, and as pharmaceutical firms know very well, it’s not new to the sector. What’s increasingly new is the use of ...
1d
Us Weekly on MSNKenan Thompson Reveals How He’ll Know It’s Time to Leave ‘SNL’ After More Than 20 Years (Exclusive)Kenan Thompson exclusively gave Us Weekly some insight into his potential retirement from ‘Saturday Night Live’ ...
New car tariffs claim their first victim as US's third-largest automaker slashes jobs; Trapped astronauts share horrifying ...
The fact, however, is that even the US would not be happy to block Indian drugs. Just 5.6% of the US’ annual pharma imports of $160 billion are from India, but the country accounts for roughly ...
Pharmaceutical companies and pharmacy retailers ... it is important to keep in mind the end result – a happy and healthy patient.
Good day and welcome to Acumen Pharma Fiscal Year 2024 Conference Call ... Yes, Jason, this is Jim Doherty. Happy to answer that question. Obviously, as we think about the subcutaneous formulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results